One particular symptom of depression often goes unnamed, even by the people who are living with it. Not really sadness, but more like a kind of flatness—the absence of pleasure, motivation, or emotional response where there used to be some. Things you used to care about and enjoy don’t seem to reach you anymore.
That symptom has a clinical name: anhedonia. It’s one of the most treatment-resistant aspects of depression we know of, and one that ketamine therapy appears to address in a way most standard treatments don’t.
What Is Anhedonia?
The word anhedonia comes from Greek and literally translates to “without pleasure.” Clinically, it refers to a reduced capacity to experience reward, motivation, or enjoyment. It’s considered a core symptom of major depression, and it comes in two ways:
- Consummatory anhedonia: The reduced ability to experience pleasure from things that are happening, like food, physical sensation, connection, and activities you’re in the middle of.
- Anticipatory anhedonia: The reduced ability to look forward to things. The absence of wanting. Not just failing to enjoy what’s in front of you, but losing the sense that anything ahead of you is worth reaching for.
Both tend to be poorly addressed by standard antidepressants. SSRIs and SNRIs can reduce the acute emotional pain of depression without fully restoring the capacity for pleasure or motivation, which is why many patients report feeling “better but not well,” or describe their depression as a kind of numbness more than active suffering.
Why Standard Antidepressants Often Fall Short
Most antidepressants work primarily on serotonin or norepinephrine systems, neurotransmitters closely tied to mood, emotional regulation, and the stress response. These medications can be effective for many dimensions of depression, but the reward system operates largely through dopamine and glutamate pathways that serotonin-based medications don’t directly target.
This is one reason anhedonia so often persists even in patients who have found partial relief from an antidepressant. The medication has addressed one part of the brain’s depressive picture while leaving the reward system largely unchanged.
How Ketamine Therapy Addresses Anhedonia
The reason why ketamine appears to reach anhedonia where other treatments have fallen short is that it works through the glutamate system. By blocking NMDA receptors, ketamine triggers a surge of glutamate activity that activates the prefrontal cortex and, critically, the nucleus accumbens, the brain region at the center of the reward circuit.
Think of it as the part of the brain responsible for the feeling of wanting things, looking forward to things, and finding things worth doing. In people with depression, chronic stress weakens the synaptic connections in this circuit. Ketamine appears to restore them, and to do so quickly, often within hours of a single session.
What makes this particularly interesting is that ketamine’s effect on anhedonia appears to work through a separate mechanism from its general antidepressant properties. It isn’t just lifting mood and bringing anhedonia along for the ride. It’s targeting the reward system directly, which is why some patients who haven’t found full relief from ketamine on standard depression measures still report significant improvement in anhedonia specifically.
What the Research Shows
The evidence base for ketamine’s antianhedonic effects has grown considerably in recent years:
- A 2024 systematic review and meta-analysis covering 16 studies and over 1,000 patients with treatment-resistant MDD and bipolar depression found that ketamine showed significant antianhedonic effects compared to baseline, with improvements observed as early as 24 hours after the first infusion.
- A 2024 study in Frontiers in Psychiatry found that ketamine alleviates anhedonia as an individual symptom domain, separate from its effect on overall depression scores. Patients classified as non-responders on standard depression measures still showed significant, measurable improvement in anhedonia specifically.
- A 2025 review in Brain (Oxford) confirmed that ketamine alleviates anhedonia within hours, with the effects of a single dose lasting for days.
The consistency across these findings is notable. Ketamine’s antianhedonic effect is rapid, appears at least partly dissociable from its general antidepressant effect, and holds up even in patients who haven’t responded to standard treatments.
Ketamine Therapy vs Other Treatments for Anhedonia
Here’s how ketamine stacks up against other available treatments when anhedonia is the primary concern.
| Ketamine | SSRIs / SNRIs | Bupropion | ECT | CBT / Therapy | |
| Targets the reward system directly | Direct | No | Partial | Indirect | No |
| Speed of onset for anhedonia | Hours to days | Weeks to months | Weeks to months | Days to weeks | Weeks to months |
| Evidence for anhedonia specifically | Strong | Limited | Moderate | Moderate | Moderate |
| Works when SSRIs have failed | Yes | N/A | Sometimes | Yes | Sometimes |
| Clinical supervision required | Yes | No | No | Yes | Yes |
| Insurance coverage | Typically self-pay | Typically yes | Typically yes | Typically yes | Typically yes |
| Cognitive side effects | Temporary dissociation during the session | Emotional blunting in some patients | Generally mild | Memory disruption most significantly | None |
Who Might Benefit From Ketamine Treatment
You may be a candidate for ketamine treatment for anhedonia if:
- Antidepressants have reduced your acute emotional pain, but haven’t restored your capacity for pleasure, motivation, or interest.
- Your primary experience of depression is emotional flatness, numbness, or disconnection rather than active sadness.
- You’ve been diagnosed with treatment-resistant depression or major depressive disorder with suicidal ideation, and anhedonia is a significant part of your symptom picture.
- You’ve noticed that things that once brought you genuine enjoyment, like relationships, creative work, or physical experience, now feel unreachable or just don’t register the way they used to.
If any of this sounds familiar, the best thing to do is bring it to a qualified provider who can look at your full history and help you understand whether ketamine treatment is the right next step. If you’re not sure where to start, the Kadelyx care team is here to talk it through with you.
Ketamine Therapy for Anhedonia at Kadelyx
If your depression looks more like emptiness than sadness, and the treatments you’ve tried haven’t addressed that, you’re not out of options yet. Book your free consultation with the Kadelyx care team to see if ketamine therapy is something worth looking into. We’ll take the time to understand your full symptom picture before recommending any path forward.
